To the best of our knowledge, these results are the first evidence that the simultaneous inhibition of both HIF-1α and STAT5 transcription factors using a decoy strategy effectively attenuates mast cell survival and alleviates AD-like skin disease in vitro and in vivo models. Here, STAT5A is linked to Alzheimer disease.